Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8926974 Methods of treating a tauopathy

Patent 8926974 was granted and assigned to iPierian, Inc. on January, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 30 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 30 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12129289 Antibodies specific for hyperphosphorylated tau and methods of use thereof
0
Edits on 17 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11958896 Antibodies recognizing tau
0
Edits on 14 Mar, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 14 Mar, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11926659 Antibodies recognizing tau
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11839654 Combination therapy
0
Edits on 3 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 3 Dec, 2023
Edits made to:
Article (+241 characters)
Article

Patent abstract

The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.

Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Irene Griswold-Prenner0
Jessica Michelle Bright0
Nancy E. Stagliano0
Sami Hussain0
Vu Dang0
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089269740
Edits on 17 May, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 08926974 Methods of treating a tauopathy US Patent 8926974 Methods of treating a tauopathy

Infobox
Patent Number
089269740
Patent Number
89269740
Edits on 28 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
iPierian, Inc.
0
Current Assignee
‌
iPierian, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
089269740
Date of Patent
January 6, 2015
0
Patent Application Number
140925390
Date Filed
November 27, 2013
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=089269740
Patent Primary Examiner
‌
Gregory S Emch
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08926974
Edits on 28 Dec, 2021
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 28 Dec, 2021
Edits made to:
Infobox (+9 properties)
‌

 US Patent 08926974 Methods of treating a tauopathy

Infobox
Is a
Patent
Patent
Patent applicant
‌
iPierian, Inc.
Current assignee
‌
iPierian, Inc.
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
08926974
Date of patent
January 6, 2015
Patent application number
14092539
Date Filed
November 27, 2013
Patent primary examiner
‌
Gregory S Emch

Find more entities like US Patent 8926974 Methods of treating a tauopathy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.